Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Sucampo Pharmaceuticals, Inc. | exh_322.htm |
EX-32.1 - EXHIBIT 32.1 - Sucampo Pharmaceuticals, Inc. | exh_321.htm |
EX-31.2 - EXHIBIT 31.2 - Sucampo Pharmaceuticals, Inc. | exh_312.htm |
EX-31.1 - EXHIBIT 31.1 - Sucampo Pharmaceuticals, Inc. | exh_311.htm |
EX-23.2 - EXHIBIT 23.2 - Sucampo Pharmaceuticals, Inc. | exh_232.htm |
EX-23.1 - EXHIBIT 23.1 - Sucampo Pharmaceuticals, Inc. | exh_231.htm |
EX-12.1 - EXHIBIT 12.1 - Sucampo Pharmaceuticals, Inc. | exh_121.htm |
EX-10.45 - EXHIBIT 10.45 - Sucampo Pharmaceuticals, Inc. | exh_1045.htm |
EX-10.44 - EXHIBIT 10.44 - Sucampo Pharmaceuticals, Inc. | exh_1044.htm |
10-K - FORM 10-K - Sucampo Pharmaceuticals, Inc. | f10k_030817p.htm |
Exhibit 21
SUBSIDIARIES OF COMPANY
Subsidiary | State or other jurisdiction of incorporation or organization | |
Sucampo Pharma Americas, LLC | Delaware | |
Sucampo LLC | Delaware | |
Sucampo AG | Switzerland | |
Sucampo Pharma, LLC | Japan | |
Sucampo Pharma Europe Ltd. | United Kingdom | |
Sucampo Acquisitions GmbH | Switzerland |